Cargando…
A regulatory role for the co-chaperone FKBP51s in PD-L1 expression in glioma
BACKGROUND: FKBP51 is a co-chaperone with isomerase activity, abundantly expressed in glioma. We previously identified a spliced isoform (FKBP51s) and highlighted a role for this protein in the upregulation of Programmed Death Ligand 1 (PD-L1) expression in melanoma. Because gliomas can express PD-L...
Autores principales: | D’Arrigo, Paolo, Russo, Michele, Rea, Anna, Tufano, Martina, Guadagno, Elia, Del Basso De Caro, Maria Laura, Pacelli, Roberto, Hausch, Felix, Staibano, Stefania, Ilardi, Gennaro, Parisi, Silvia, Romano, Maria Fiammetta, Romano, Simona |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5620257/ https://www.ncbi.nlm.nih.gov/pubmed/28978117 http://dx.doi.org/10.18632/oncotarget.19309 |
Ejemplares similares
-
FKBP51 increases the tumour-promoter potential of TGF-beta
por: Romano, Simona, et al.
Publicado: (2014) -
FKBP51 Affects TNF-Related Apoptosis Inducing Ligand Response in Melanoma
por: Tufano, Martina, et al.
Publicado: (2021) -
FKBP51 Immunohistochemical Expression: A New Prognostic Biomarker for OSCC?
por: Russo, Daniela, et al.
Publicado: (2017) -
The splicing FK506-binding protein-51 isoform plays a role in glioblastoma resistance through programmed cell death ligand-1 expression regulation
por: D’Arrigo, Paolo, et al.
Publicado: (2019) -
Alternative macrophage polarisation associated with resistance to anti-PD1 blockade is possibly supported by the splicing of FKBP51 immunophilin in melanoma patients
por: Troiani, Teresa, et al.
Publicado: (2020)